Back to Search
JENNIFER FEIGHNER, M.D.
M.D.
Hospitalist Physician
NPI: 1639191265IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
34059(OK)
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 2003
Research & Publications (13)
Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
PMID 18090505·Int Clin Psychopharmacol·2008
3-trial
Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder.
PMID 16259645·Int J Neuropsychopharmacol·2006
3-trial
Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers.
PMID 16130176·Biopharm Drug Dispos·2005
4-observational
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression.
PMID 14985919·Psychopharmacology (Berl)·2004
4-observational
Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment.
PMID 12974986·Int J Neuropsychopharmacol·2003
3-trial
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
PMID 11939866·JAMA·2002
3-trial
Clinical pharmacokinetic studies with INN 00835 (nemifitide), a novel pentapeptide antidepressant.
PMID 11891671·Biopharm Drug Dispos·2002
3-trial
Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression.
PMID 11712623·Int Clin Psychopharmacol·2001
3-trial
Cluster analysis of clinical data to identify subtypes within a study population following treatment with a new pentapeptide antidepressant.
PMID 11343601·Int J Neuropsychopharmacol·2000
8-other
A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression.
PMID 11099750·J Affect Disord·2000
3-trial
Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid?
PMID 11068969·J Consult Clin Psychol·2000
4-observational
Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders.
PMID 11015524·Pediatrics·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
4.7(71)
Via Bitterroot Health - Imaging · 2 locations total
- Address
- 1200 WESTWOOD DR
HAMILTON, MT 59840 - Phone
- (406) 363-2211
- Website
- bitterroothealth.org
4.7(71)
See full reviewsQuick Facts
- NPI
- 1639191265
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 23
- Publications
- 13
Are you this provider?
Claim Your Profile